included depressed cellular and humoral immunity, and, in particular, low serum immunoglobulin A (IgA) (Sorrell et al., 1971; Grob and Herold, 1972; Slavin et al., 1974) . In a detailed study cellmediated immunity was measured in vivo by skin testing with ubiquitous recall antigens, and in vitro by measurement of lymphocyte DNA and RNA synthesis. It was found to be depressed; low IgA levels together with defective antibody production to Salmonella typhii and tetanus toxoid were also found (Sorrell and Forbes, 1975) . It was subsequently suggested that epilepsy with constitutional characteristics might predispose to low IgA, and that the low IgA only occurs when hydantoins are given (Fontana et al., 1976) . We, therefore, studied a large group of patients on phenytoin and other anticonvulsants to determine their immunological status and the relation of that to their histocompatibility antigens.
Patients and methods
Eighty-three patients were studied (40 female and 43 male) whose ages ranged between 17 
SERUM LEVELS OF ANTICONVULSANTS
The serum levels of sodium phenytoin, phenobarbitone, and primidone were measured in all patients using a gas chromatography method (Goudie and Burnett, 1973) .
SERUM FOLATE LEVELS
These were determined by the Lactobacillus casei method (Herbert, 1966 (Sorrell and Forbes, 1975) .
71).
The mechanisms involved in producing these nd other immune deficiencies are unknown, but it has been rgA on suggested that genetic factors may operate (Fontana et al., 1976) . Our results show a conspicuous impairment of both T cell function and IgA metabolism in patients on long-term anticonvulsant therapy. The technique used to measure T cell function was the in vitro measurement of peripheral bloodlymphocyte protein synthesis-this technique is a sensitive and reliable index of thymus-derived lymphocyte function (Pauly et al., 1973) . Impaired immune responses by this method have previously been demonstrated in patients with autoimmune diseases, drug reactions, and malignancies (Thomas et al., 1975; Behan et al., 1976; Simpson et al., 1976) .
It is possible that phenytoin causes depressed T cell function by direct action on cells. This hypothesis is supported by evidence of the action of phenytoin on normal lymphocytes in culture, where it produces depression of both DNA and RNA synthesis (Sorrell and Forbes, 1975) . In our patients this effect may have been operative, although the depression was not related to phenytoin dosage or blood level. Similar depressed lymphocytic responses were also found in patients taking other anticonvulsants. A factor common to both groups was a low serum folate level; this is known to affect cellular nucleic acid synthesis (Norris and Pratt, 1974) .
Nearly a quarter of the patients (23.2%) who were on phenytoin had low serum IgA levels, while only one patient from the other group (patients on other anticonvulsants) had even a slightly reduced level, and it is interesting to note that this patient was on carbamazepine, which was reported previously to cause IgA deficiency in 11% of patients (Sorrell and Forbes, 1975) . In the patients affected there was no relationship between phenytoin dosage or serum level and the amount of IgA depression. The reduced serum primidone levels which were found in patients with low serum IgA have been reported previously (Slavin et al., 1974) , but the explanation of this is still unknown.
Low serum IgA levels have been found in patients with a variety of autoimmune disorders, including systemic lupus erythematosus (Tomasi, 1968) , pernicious anaemia (Odgers and Wangel, 1968 ), Sjogren's syndrome (Claman et al., 1966) , and myasthenia gravis (Simpson et al., 1976) , persistent viral and fungal infections (Claman et al., 1966; Hobbs, 1968) , and in a variety of malignancies usually affecting the lymphoid system (Scheurlen et al., 1971) . IgA function is related to intact thymic function (Lancet, 1975) : it is known that congenitally athymic nude mice have IgA deficiency although they have many IgA bearing B lymphocytes (Bankhurst and Warner, 1972) . This is similar to patients with IgA deficiency secondary to phenytoin therapy (Sorrell and Forbes, 1975) who also have normal numbers of IgA bearing B lymphocytes but low serum IgA levels. In animal experiments impaired immune responses, atrophy of thymic and lymphoid tissue, and increased incidence of lymphoid tumour were produced by chronic phenytoin ingestion (Kruger and Harris, 1972) .
The most interesting association we found was the increased frequency of the histocompatibility antigen HLA-A2 in those patients taking phenytoin with low IgA levels as compared to those taking phenytoin but with normal serum IgA. The sample size of our patients was small, and there is a known high frequency of HLA-A2 in the west of Scotland (nearly 48%), but the difference between both groups was striking. Further studies will be needed to clarify this finding.
Our 
